Partners Roberto Arena and Fernando Camarena were quoted in the El Economista article, “Falta claridad en estímulos fiscales para la frontera norte” about the Decree of Fiscal Incentives North Border Region, signed by President Andrés Manuel López Obrador.
Camarena stated that the reduction in the VAT rate and the ISR will be reflected in a reduction of collection; however, he added that the intent is that this reduction will be off-set once the increase in commercial and production activity is achieved in the cities where the measures will be applied.
Arena explained that the tax benefits provided in the decree will be valid for two years. This period will allow enough time to evaluate the impact of these measures and to consider whether they should be made permanent by law. Furthermore, Arena estimated that the positive effects of these measures may be seen in as little as six months
Camarena stated that the reduction in the VAT rate and the ISR will be reflected in a reduction of collection; however, he added that the intent is that this reduction will be off-set once the increase in commercial and production activity is achieved in the cities where the measures will be applied.
Arena explained that the tax benefits provided in the decree will be valid for two years. This period will allow enough time to evaluate the impact of these measures and to consider whether they should be made permanent by law. Furthermore, Arena estimated that the positive effects of these measures may be seen in as little as six months
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.